SC
CELG

Savant Capital’s Celgene Corp CELG Stock Holding History

Savant Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,519
Closed -$250K – 358
2019
Q3 		$250K Buy
2,519
+160
+7% +$15.2K 0.03% 287
2019
Q2 		$218K Buy
2,359
+145
+7% +$13.8K 0.03% 308
2019
Q1 		$209K Buy
+2,214
New +$194K 0.04% 267
2018
Q2 		– Sell
-2,260
Closed -$202K – 298
2018
Q1 		$202K Sell
2,260
-40
-2% -$3.84K 0.04% 279
2017
Q4 		$240K Sell
2,300
-112
-5% -$12.6K 0.05% 254
2017
Q3 		$352K Buy
2,412
+62
+3% +$8.45K 0.08% 179
2017
Q2 		$305K Buy
2,350
+20
+0.9% +$2.45K 0.07% 199
2017
Q1 		$290K Buy
2,330
+130
+6% +$15.6K 0.07% 204
2016
Q4 		$255K Hold
2,200
– – 0.07% 217
2016
Q3 		$230K Buy
2,200
+50
+2% +$5.41K 0.06% 220
2016
Q2 		$212K Sell
2,150
-70
-3% -$7.24K 0.06% 234
2016
Q1 		$222K Sell
2,220
-1,607
-42% -$165K 0.07% 205
2015
Q4 		$458K Buy
3,827
+1,227
+47% +$142K 0.14% 117
2015
Q3 		$281K Buy
2,600
+160
+7% +$19.9K 0.1% 164
2015
Q2 		$282K Sell
2,440
-66
-3% -$7.54K 0.09% 165
2015
Q1 		$289K Buy
2,506
+86
+4% +$10.3K 0.1% 166
2014
Q4 		$271K Hold
2,420
– – 0.1% 171
2014
Q3 		$229K Sell
2,420
-108
-4% -$9.75K 0.1% 181
2014
Q2 		$217K Buy
+2,528
New +$192K 0.09% 177
2014
Q1 		– Sell
-2,424
Closed -$205K – 185
2013
Q4 		$205K Buy
+2,424
New +$192K 0.1% 162

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Savant Capital's CELG Position: Q4 2019 in Review

Savant Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,519 shares — an estimated $250K sold.

Savant Capital first reported a position in CELG in Q4 2013 and held it in 20 quarters. The position peaked at $458K in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Savant Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Savant Capital sold 2,519 Celgene Corp shares in Q4 2019, an estimated $250K.
  • Savant Capital first reported a position in Celgene Corp in Q4 2013 and held it in 20 quarters.
  • Savant Capital's Celgene Corp position peaked at $458K in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Savant Capital's 13F filing for Q4 2019, filed 31 Jan 2020.